Klena J W, Cameron B H, Langer J C, Winthrop A L, Perez C R
Department of Surgery, Janet Weis Children's Hospital, Geisinger Medical Center, Danville, PA 17821, USA.
J Am Coll Surg. 1998 Oct;187(4):404-8. doi: 10.1016/s1072-7515(98)00190-2.
Video-assisted thoracoscopic debridement (VATD) is a new method of managing pediatric empyema. The purpose of this retrospective study was to determine the relation between the timing of VATD and its success in avoiding the need for open decortication.
Twenty-one children aged 3 to 16 years (mean, 8 years) with symptomatic, loculated, parapneumonic empyema were treated with VATD at two tertiary pediatric centers between 1994 and 1997. The preoperative duration of symptoms, hospitalization, and previous need for thoracostomy drainage were compared between patients having VATD only and those who subsequently required a thoracotomy and decortication. Statistical analysis used the Wald chi-square test or Fisher's exact test with p < 0.05 considered significant.
Video-assisted thoracoscopic debridement was successful in 15 patients (group 1) and unsuccessful in six patients (group 2), who required a thoracotomy and decortication. Group 1 had a shorter mean duration of preoperative symptoms (13 versus 27 days; p=0.03), a shorter median duration of preoperative hospitalization (6 versus 18 days; p=0.04), and a lower incidence of previous thoracostomy drainage (4/15 versus 5/6; p=0.05).
The technique of VATD is most likely to be successful when used within one week of diagnosis of a loculated parapneumonic empyema. A prospective trial comparing VATD with intrapleural fibrinolytic agents for the initial treatment of pediatric empyema is needed.
电视辅助胸腔镜清创术(VATD)是治疗小儿脓胸的一种新方法。这项回顾性研究的目的是确定VATD的时机与其成功避免开胸剥脱术之间的关系。
1994年至1997年间,在两家三级儿科中心对21例年龄在3至16岁(平均8岁)、有症状、局限性、肺炎旁脓胸的儿童进行了VATD治疗。比较了仅接受VATD治疗的患者与随后需要开胸和剥脱术的患者术前症状持续时间、住院时间以及先前胸腔造口引流的需求。统计分析采用Wald卡方检验或Fisher精确检验,p<0.05被认为具有统计学意义。
电视辅助胸腔镜清创术在15例患者中成功(第1组),在6例患者中失败(第2组),这6例患者需要开胸和剥脱术。第1组术前症状的平均持续时间较短(13天对27天;p=0.03),术前住院的中位持续时间较短(6天对18天;p=0.04),先前胸腔造口引流的发生率较低(4/15对5/6;p=0.05)。
当在局限性肺炎旁脓胸诊断后一周内使用时,VATD技术最有可能成功。需要进行一项前瞻性试验,比较VATD与胸膜内纤维蛋白溶解剂在小儿脓胸初始治疗中的效果。